4//SEC Filing
Stilley William B. III 4
Accession 0001213900-22-009432
CIK 0001513525other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:00 PM ET
Size
12.2 KB
Accession
0001213900-22-009432
Insider Transaction Report
Form 4
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2022-02-23+250,000→ 1,187,646 total
Footnotes (1)
- [F1]The restricted shares of Adial Pharmaceuticals, Inc. (the "Company") common stock, par value $0.001 per share (the "Common Stock"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date.
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001718069
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:00 PM ET
- Size
- 12.2 KB